EP0396715A1 - Phage resistant ice nucleating pseudomonas syringae - Google Patents

Phage resistant ice nucleating pseudomonas syringae

Info

Publication number
EP0396715A1
EP0396715A1 EP89912708A EP89912708A EP0396715A1 EP 0396715 A1 EP0396715 A1 EP 0396715A1 EP 89912708 A EP89912708 A EP 89912708A EP 89912708 A EP89912708 A EP 89912708A EP 0396715 A1 EP0396715 A1 EP 0396715A1
Authority
EP
European Patent Office
Prior art keywords
atcc
phage
bacteriophage
ice nucleating
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP89912708A
Other languages
German (de)
French (fr)
Inventor
Richard Joseph Laduca
Kimberly Black Sweeting
Lisa Rosen Lievense
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco US Inc
Original Assignee
Eastman Kodak Co
Genencor International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co, Genencor International Inc filed Critical Eastman Kodak Co
Publication of EP0396715A1 publication Critical patent/EP0396715A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Definitions

  • the present invention relates to microorganisms that are useful for ice nucleating. More particularly, the microorganisms are bacteriophage-resistant mutants of Pseudomonas svringae.
  • Background In US Patent 4,200,228 there is disclosed a method for the making of snow whereby microorganisms are included in droplets that are sprayed into the air.
  • the microorganisms that are used are of the type which are known to promote ice nucleation. As a result, snow can be made at temperatures that are much higher than are ordinarily possible.
  • a typical microorganism that is useful in this method is a Pseudomonad and particularly Pseudomonas syringae.
  • Pseudomonas svringae bacteria are susceptible to lytic bacteriophage infection. These bacteriophage are readily found in the natural environment. When a large scale fermentation run is infected with bacteriophage, the growing cells lyse and therefore do not reproduce. Often, the entire run must be discarded. Contamination of industrial environments with virulent bacteriophage thus represents a serious problem for efficient and economical production of ice nucleating Pseudomonas syrjngae-
  • Resistance to phage infection is usually accomplished by changes to the bacteriophage attachment receptors on the cell surface or to alterations in the cell wall and membrane composition.
  • the ice nucleating capability of Pseudomonas syringae is also associated with cell surface proteins.
  • phage-resistant derivatives of Pseudomonas syringae would have altered ice nucleating capabilities.
  • an ice nucleating Pseudomonas syringae that is resistant to bacteriophage selected from the group consisting of ATCC 40491, ATCC 40492 and ATCC 40493.
  • Ice nucleating, bacteriophage-resistant strains of Pseudomonas svringae are made by challenging the parent with the bacteriophage.
  • the method is described in detail below.
  • the strain is considered to be bacteriophage-resistant if the bacterial isolate has the ability to grow and multiply under conditions in which the multiplicity of infection is greater than or equal to 1.0.
  • the multiplicity of infection is defined as the number of plaque forming units of phage lysate divided by the number of bacterial cells in the starting culture.
  • Mutant phage-resistant strains are then screened for ice nucleating activity.
  • Preferred phage-resistant strains have ice nucleating activity and growth that are comparable to the parent strain, e.g.
  • ATCC 53543 when both are grown under the conditions described in European patent application 88103346.8, filed 4 March 1988.
  • the currently preferred medium for the comparison described above contains: 90 g/L sucrose; 45 g/L monosodium glutamate; 4 g/L magnesium sulfate; 2.75 g/L potassium sulfate; .112 g/L iron sulfate; and .0024 g/L zinc sulfate.
  • the mutant is about the same as the parent or better.
  • the phage-resistant strain can be grown in a conventional manner. Particularly preferred methods and media are described in European patent applications 87113771.7 and 87113772.5, filed 21 September 1987; 87118942.9, filed 21 December 1987 and 88103346.8, filed 4 March 1988.
  • the ice nucleating microorganism is re ⁇ covered in a dry form.
  • the microorganism from the fermentation can be prepared in dried form in a number of ways. Spray drying and freeze drying are typical examples. Any drying process will reduce the INA to a certain extent.
  • One preferred method that preserves a large amount of the INA that is produced in the fermentor is the process that is described in United States Patent 4,706,463.
  • the medium is cooled, concentrated, run into a cryo ⁇ genic liquid to form pellets and then the pellets are freeze dried at relatively low temperature.
  • a process for spray drying ice nucleating microorganisms is described in European patent application 89103483.7, filed 28 February 1989. Methods;
  • bacteriophage have been designated as types ATCC 40491, ATCC 40492 and ATCC 40493.
  • the phage differ on a molecular level as determined by restriction endonuclease digestion of their double—stranded DNA.
  • the pattern of DNA fragments generated following restriction digestion indicates that phage types ATCC 40491 and ATCC 40493 are similar, however phage ATCC 40493 is capable of lytic infection on a phage ATCC 40491— resistant derivative of strain ATCC 53543. This observation indicates that minor differences in the genomes of these two bacteriophage isolates result in variations in host infectivity.
  • Phage types ATCC 40492 and ATCC 40494 (a fourth isolate from the fermentation environment) differ greatly in molecular organization compared to phage types ATCC 40491 and ATCC 40493 based on restriction patterns. Southern hybridization of phage DNA from all four phage types
  • Bacteriophage Pseudomonas syringae bacteriophage were initially isolated from fermentation broths exhibiting a rapid loss of cell density during the fermentation process. Bacteriophage are separated from cells and cell debris by centrifugation at 10,000 RPM for 15 minutes at 4 ⁇ C. To further purify the phage particles, the phage lysate from the centrifugation step is filtered through a low protein binding 0.2 ⁇ m filter. Bacteriophage suspensions are stored as liquid stocks in sterile test tubes at 4 ⁇ C.
  • the titer of phage particles is determined by plating 0.1 ml of serially diluted phage lysate suspensions (10 , 10 , 10 , 10 , and 10 —8) with 0.1 ml of an overnight phage-sensitive Pseudomonas syringae culture (e.g. strain ATCC 53543) onto Pseudomonas agar F plates containing 38 g/1 Pseudomonas agar F (Medium B from Gibco Laboratories USA) and 10 g/1 glycerol. Plates are incubated overnight at 24°C. Lytic infection is evidenced by the formation of plaques or circular clearing zones on a lawn of non—infected bacterial growth.
  • Phage titer (the number of plaque forming units per ml of lysate) is determined by counting the plaques and computing the number of phage per ml in the original undiluted lysate. The appearance of 100 plaques on a o plate from the 10 dilution tube of lysate thus indicates a phage titer of 1.0 x 10 plaque forming units in the undiluted lysate.
  • bacteriophage were added to an exponentially growing bacterial culture of strain ATCC 53543 at a multiplicity of infection of 1.0 (i.e., one plaque forming unit of phage lysate to every bacterial cell in the culture). Incubation was continued for 24 hours at 24 ⁇ C. Isolation of bacteriophage from the lysate and determination of phage titer were accomplished as described earlier. This process was continued until phage titers reached a concentration of 1.0 x 10 plaque forming units per ml.
  • the INA (ice nucleating activity) is calculated using conventional techniques.
  • the INA is determined by placing a plurality of microorganism containing water droplets (10 ⁇ l) on paraffin coated aluminum foil. The foil is maintained at -5 ⁇ C by placing it on a constant temperature bath. Details regarding this procedure are found in the literature, for example, Vali, Quantitative Evalua ⁇ tion of Experimental Results on the Heterogeneous Freezing of Supercooled Liquids, J. Atoms Sci., 28. 402-409 (1971). Examples 1 &.2: Isolation of Bacteriophage- Resistant Derivatives of ATCC 53543
  • Spontaneous phage-resistant derivatives of strain ATCC 53543 were isolated following exposure of the bacteria to phage types ATCC 40491,-ATCC 40492 o and ATCC 40493. Approximately 2.5 x 10 plaque forming units of each of the phage types and 1 x o 10 bacteria were spread onto a Pseudomonas agar F plate (previously described). The plates were incubated at 24°C for 24 to 36 hours. Colonies resistant to phage infection were picked from the cleared lawn of lysed phage-sensitive bacteria. Resistant colonies typically were observed after 36 hours of growth.
  • Colonies resistant to infection by phage types ATCC 40491, ATCC 40492 and ATCC 40493 were screened in RK medium (previously described) for the ability to express at high levels the ice nucleation phenotype associated with the phage-sensitive ATCC 53543 parent. Ice nucleation assays were performed using the standard drop freezing method (described in Methods section D). All isolates were re-tested for bacteriophage ATCC 40491-, ATCC 40492-, ATCC 40493—resistance during this screening process.
  • strain ATCC 53811 One of the isolates, designated as strain ATCC 53811 was chosen for further analysis based on its combined resistance to phage types ATCC 40491, ATCC 40492, and ATCC 40493, its fermentation performance and ability to express the ice nucleation phenotype.
  • a second phage-resistant strain designated ATCC 53810 was isolated in a similar manner as described above except that a phage ATCC 40491-resistant strain was used as the starting strain. It also expressed the ice nucleating phenotype.
  • phage ATCC 40494 phage ATCC 40494 isolated from the local environment. It is important to note that resistance to this fourth bacteriophage was obtained without prior exposure of the microorganisms to phage ATCC 40494. Resistance of strains ATCC 53811 and ATCC 53810 to infection by other broad host range Pseudomonas bacteriophage has also been demonstrated.
  • Pseudomonas syringae which can be used in a fermentation environment which may contain lytic bacteriophage.
  • ice nucleating activity and growth are comparable to the parent strain.
  • the present invention can be used in the large scale manufacture of ice nucleating microorganisms which can be used in making snow and ice.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des souches de Pseudomonas syringae mutants, résistant aux infections lytiques de bactériophages. Les microorganismes retiennent les propriétés de nucléation de glace du microorganisme parent. Ledit microorganisme est par conséquent utile dans la fabrication de neige, d'îles de glace ainsi que dans d'autres procédés de fabrication de glace.The invention relates to mutant strains of Pseudomonas syringae resistant to lytic infections of bacteriophages. The microorganisms retain the ice nucleating properties of the parent microorganism. Said microorganism is therefore useful in the manufacture of snow, ice islands as well as in other methods of making ice.

Description

PHAGE RESISTANT ICE NUCLEATING
PSEUDOMONAS SYRINGAE
Technical Field
The present invention relates to microorganisms that are useful for ice nucleating. More particularly, the microorganisms are bacteriophage-resistant mutants of Pseudomonas svringae. Background In US Patent 4,200,228 there is disclosed a method for the making of snow whereby microorganisms are included in droplets that are sprayed into the air. The microorganisms that are used are of the type which are known to promote ice nucleation. As a result, snow can be made at temperatures that are much higher than are ordinarily possible. A typical microorganism that is useful in this method is a Pseudomonad and particularly Pseudomonas syringae.
In US Patent 4,637,217 there is disclosed a method for accelerating the freezing of sea water. Ice nucleating microorganisms are added to the water source, in this case sea water. The sea water is then distributed, such as by spraying, to make large ice structures. These ice structures are useful for oil drilling platforms in the polar regions. In this application of the ice nucleating microorganisms, the conditions of spraying are adjusted to promote the formation of ice on the surface rather than snow in the air. In addition to spraying, the patent also discloses other methods of distributing the ice nucleated sea water. For example, an area that is surrounded by a dam can be flooded by the nucleated sea water and allowed to freeze.
It is apparent that there is a need for methods for the production of large amounts of the ice nucleating microorganisms. To meet this need, Pseudomonas syringae is grown in large scale fermentors. The microorganism is then recovered and used in a dry form.
Unfortunately, Pseudomonas svringae bacteria are susceptible to lytic bacteriophage infection. These bacteriophage are readily found in the natural environment. When a large scale fermentation run is infected with bacteriophage, the growing cells lyse and therefore do not reproduce. Often, the entire run must be discarded. Contamination of industrial environments with virulent bacteriophage thus represents a serious problem for efficient and economical production of ice nucleating Pseudomonas syrjngae-
Resistance to phage infection is usually accomplished by changes to the bacteriophage attachment receptors on the cell surface or to alterations in the cell wall and membrane composition. However, it is known that the ice nucleating capability of Pseudomonas syringae is also associated with cell surface proteins. Thus, it was anticipated that phage-resistant derivatives of Pseudomonas syringae would have altered ice nucleating capabilities.
Thus, the problem to be solved was to produce a phage—resistant Pseudomonas syringae that retained its ice nucleating capability. PisciQsuτe of the Invention
In accordance with the present invention there is provided an ice nucleating Pseudomonas syringae that is resistant to bacteriophage selected from the group consisting of ATCC 40491, ATCC 40492 and ATCC 40493.
The following deposits are pertinent to the present invention. All of the deposits were made according to the Budapest Treaty with the American Type Culture Collection in Rockville Maryland, USA. ATCC 535.43 23 Sept. 1986, P. syringae (parent) ATCC 53810 1 Sept. 1988, P. syringae (phage1) ATCC 53811 1 Sept. 1988, P. syringae (phage1) ATCC 40491 1 Sept. 1988, bacteriophage ATCC 40492 1 Sept. 1988, bacteriophage ATCC 40493 1 Sept. 1988, bacteriophage ATCC 40494 1 Sept. 1988, bacteriophage
Ice nucleating, bacteriophage-resistant strains of Pseudomonas svringae are made by challenging the parent with the bacteriophage. The method is described in detail below. The strain is considered to be bacteriophage-resistant if the bacterial isolate has the ability to grow and multiply under conditions in which the multiplicity of infection is greater than or equal to 1.0. The multiplicity of infection is defined as the number of plaque forming units of phage lysate divided by the number of bacterial cells in the starting culture. Mutant phage-resistant strains are then screened for ice nucleating activity. Preferred phage-resistant strains have ice nucleating activity and growth that are comparable to the parent strain, e.g. ATCC 53543, when both are grown under the conditions described in European patent application 88103346.8, filed 4 March 1988. The currently preferred medium for the comparison described above contains: 90 g/L sucrose; 45 g/L monosodium glutamate; 4 g/L magnesium sulfate; 2.75 g/L potassium sulfate; .112 g/L iron sulfate; and .0024 g/L zinc sulfate. By comparable, we mean that the mutant is about the same as the parent or better.
Once the phage-resistant strain is isolated, it can be grown in a conventional manner. Particularly preferred methods and media are described in European patent applications 87113771.7 and 87113772.5, filed 21 September 1987; 87118942.9, filed 21 December 1987 and 88103346.8, filed 4 March 1988. The ice nucleating microorganism is re¬ covered in a dry form. The microorganism from the fermentation can be prepared in dried form in a number of ways. Spray drying and freeze drying are typical examples. Any drying process will reduce the INA to a certain extent. One preferred method that preserves a large amount of the INA that is produced in the fermentor is the process that is described in United States Patent 4,706,463. In this process, the medium is cooled, concentrated, run into a cryo¬ genic liquid to form pellets and then the pellets are freeze dried at relatively low temperature. A process for spray drying ice nucleating microorganisms is described in European patent application 89103483.7, filed 28 February 1989. Methods;
A. Growth of Bacterial Cultures
Cultures of Pseudomonas syringae strain ATCC 53543 and all phage-resistant derivatives of this strain were grown in RK medium containing 80 g/1 mannitol, 20 g/1 yeast extract and 1 g/1 MgS04«7H20). Cultures (25ml) were incubated in 250 ml erlenmeyer flasks with aeration at 24βC. B. Pescription of Bacteriophage Phage-resistant derivatives of Pseudomonas syringae strain ATCC 53543 were isolated following exposure to three bacteriophage types isolated from the fermentation environment. These bacteriophage have been designated as types ATCC 40491, ATCC 40492 and ATCC 40493. The phage differ on a molecular level as determined by restriction endonuclease digestion of their double—stranded DNA. The pattern of DNA fragments generated following restriction digestion indicates that phage types ATCC 40491 and ATCC 40493 are similar, however phage ATCC 40493 is capable of lytic infection on a phage ATCC 40491— resistant derivative of strain ATCC 53543. This observation indicates that minor differences in the genomes of these two bacteriophage isolates result in variations in host infectivity. Phage types ATCC 40492 and ATCC 40494 (a fourth isolate from the fermentation environment) differ greatly in molecular organization compared to phage types ATCC 40491 and ATCC 40493 based on restriction patterns. Southern hybridization of phage DNA from all four phage types
32 with P-labeled DNA probes from phage ATCC 40493 indicated a high degree of homology between phage types ATCC 40491, ATCC 40492 and ATCC 40493. No homology of phage ATCC40493 DNA to phage ATCC 40494 DNA was observed.
C. Isolation of Bacteriophage Pseudomonas syringae bacteriophage were initially isolated from fermentation broths exhibiting a rapid loss of cell density during the fermentation process. Bacteriophage are separated from cells and cell debris by centrifugation at 10,000 RPM for 15 minutes at 4βC. To further purify the phage particles, the phage lysate from the centrifugation step is filtered through a low protein binding 0.2 μm filter. Bacteriophage suspensions are stored as liquid stocks in sterile test tubes at 4βC.
The titer of phage particles is determined by plating 0.1 ml of serially diluted phage lysate suspensions (10 , 10 , 10 , 10 , and 10 —8) with 0.1 ml of an overnight phage-sensitive Pseudomonas syringae culture (e.g. strain ATCC 53543) onto Pseudomonas agar F plates containing 38 g/1 Pseudomonas agar F (Medium B from Gibco Laboratories USA) and 10 g/1 glycerol. Plates are incubated overnight at 24°C. Lytic infection is evidenced by the formation of plaques or circular clearing zones on a lawn of non—infected bacterial growth. Phage titer (the number of plaque forming units per ml of lysate) is determined by counting the plaques and computing the number of phage per ml in the original undiluted lysate. The appearance of 100 plaques on a o plate from the 10 dilution tube of lysate thus indicates a phage titer of 1.0 x 10 plaque forming units in the undiluted lysate.
To increase phage titers, bacteriophage were added to an exponentially growing bacterial culture of strain ATCC 53543 at a multiplicity of infection of 1.0 (i.e., one plaque forming unit of phage lysate to every bacterial cell in the culture). Incubation was continued for 24 hours at 24βC. Isolation of bacteriophage from the lysate and determination of phage titer were accomplished as described earlier. This process was continued until phage titers reached a concentration of 1.0 x 10 plaque forming units per ml.
D. The INA (ice nucleating activity) is calculated using conventional techniques. The INA is determined by placing a plurality of microorganism containing water droplets (10 μl) on paraffin coated aluminum foil. The foil is maintained at -5βC by placing it on a constant temperature bath. Details regarding this procedure are found in the literature, for example, Vali, Quantitative Evalua¬ tion of Experimental Results on the Heterogeneous Freezing of Supercooled Liquids, J. Atoms Sci., 28. 402-409 (1971). Examples 1 &.2: Isolation of Bacteriophage- Resistant Derivatives of ATCC 53543
Spontaneous phage-resistant derivatives of strain ATCC 53543 were isolated following exposure of the bacteria to phage types ATCC 40491,-ATCC 40492 o and ATCC 40493. Approximately 2.5 x 10 plaque forming units of each of the phage types and 1 x o 10 bacteria were spread onto a Pseudomonas agar F plate (previously described). The plates were incubated at 24°C for 24 to 36 hours. Colonies resistant to phage infection were picked from the cleared lawn of lysed phage-sensitive bacteria. Resistant colonies typically were observed after 36 hours of growth.
Colonies resistant to infection by phage types ATCC 40491, ATCC 40492 and ATCC 40493 were screened in RK medium (previously described) for the ability to express at high levels the ice nucleation phenotype associated with the phage-sensitive ATCC 53543 parent. Ice nucleation assays were performed using the standard drop freezing method (described in Methods section D). All isolates were re-tested for bacteriophage ATCC 40491-, ATCC 40492-, ATCC 40493—resistance during this screening process. One of the isolates, designated as strain ATCC 53811 was chosen for further analysis based on its combined resistance to phage types ATCC 40491, ATCC 40492, and ATCC 40493, its fermentation performance and ability to express the ice nucleation phenotype. A second phage-resistant strain designated ATCC 53810 was isolated in a similar manner as described above except that a phage ATCC 40491-resistant strain was used as the starting strain. It also expressed the ice nucleating phenotype.
Both phage-resistant microorganisms have been shown to be resistant to a fourth phage type (phage ATCC 40494) isolated from the local environment. It is important to note that resistance to this fourth bacteriophage was obtained without prior exposure of the microorganisms to phage ATCC 40494. Resistance of strains ATCC 53811 and ATCC 53810 to infection by other broad host range Pseudomonas bacteriophage has also been demonstrated. These data suggest that alterations occurring in the original ATCC 53543 strain following exposure to phage types ATCC 40491, ATCC 40492, and ATCC 40493 have resulted in infection resistance to a broad range of other Pseudomonas phage types in strains ATCC 53811 and ATCC 53810. The novel alterations to the cell surface responsible for the resistance to lytic infection by phage types previously unseen by these organisms has not negatively effected ice nucleation capabilities.
Several other strains of Pseudomonas syringae were made in a similar manner. Each of the strains were phage-resistant and had ice nucleating activity. The previously mentioned ATCC 53810 and 53811 are preferred since they exhibit ice nucleating activity and growth that are comparable to the parent ATCC 53543 strain. Thus, the present invention provides
Pseudomonas syringae which can be used in a fermentation environment which may contain lytic bacteriophage. In preferred embodiments, ice nucleating activity and growth are comparable to the parent strain.
Industrial Applicability
The present invention can be used in the large scale manufacture of ice nucleating microorganisms which can be used in making snow and ice.

Claims

Claim :
1. An ice nucleating Pseudomonas syringae that is resistant to bacteriophage selected from the group consisting of ATCC 40491, ATCC 40492 and ATCC 40493.
2. An ice nucleating Pseudomonas syringae according to claim 1 wherein the parent is Pseudomonas svringae ATCC 53543.
3. ATCC 53810.
4. ATCC 53811.
5. An ice nucleating Pseudomonas syringae according to claim 1 which is also resistant to ATCC 40494.
EP89912708A 1988-11-17 1989-11-13 Phage resistant ice nucleating pseudomonas syringae Withdrawn EP0396715A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US272603 1981-06-11
US27260388A 1988-11-17 1988-11-17

Publications (1)

Publication Number Publication Date
EP0396715A1 true EP0396715A1 (en) 1990-11-14

Family

ID=23040497

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89912708A Withdrawn EP0396715A1 (en) 1988-11-17 1989-11-13 Phage resistant ice nucleating pseudomonas syringae

Country Status (6)

Country Link
EP (1) EP0396715A1 (en)
JP (1) JPH03502285A (en)
KR (1) KR900702003A (en)
AU (1) AU4518989A (en)
CA (1) CA2003097A1 (en)
WO (1) WO1990005776A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112359024B (en) * 2020-11-14 2022-02-11 菲吉乐科(南京)生物科技有限公司 Pseudomonas syringae bacteriophage and composition, kit and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375734A (en) * 1981-08-17 1983-03-08 University Patents, Inc. Protection of plants against frost injury using ice nucleation-inhibiting species-specific bacteriophages

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9005776A1 *

Also Published As

Publication number Publication date
CA2003097A1 (en) 1990-05-17
JPH03502285A (en) 1991-05-30
AU4518989A (en) 1990-06-12
WO1990005776A1 (en) 1990-05-31
KR900702003A (en) 1990-12-05

Similar Documents

Publication Publication Date Title
Lomovskaya et al. Characterization of temperate actinophage φC31 isolated from Streptomyces coelicolor A3 (2)
Thorne Transduction in Bacillus subtilis
Gašić et al. Isolation and characterization of Xanthomonas euvesicatoria bacteriophages
Taylor et al. Transduction of Bacillus licheniformis and Bacillus subtilis by each of two phages
CA1185547A (en) Plasmid pel 7 and related cloning vectors for use in streptomyces and related organisms
GB2034717A (en) Method for preparing recombinant
De Lencastre et al. Genetic control of population structure in heterogeneous strains of methicillin resistant Staphylococcus aureus
Porter et al. Characterization of some pneumococcal bacteriophages
Bertani Host-dependent induction of phage mutants and lysogenization
Moebus Further investigations on the concentration of marine bacteriophages in the water around Helgoland, with reference to the phage-host systems encountered
Herman et al. Isolation and characterization of a generalized transducing bacteriophage for Acinetobacter
Reilly et al. An actinophage for Streptomyces griseus
West et al. Isolation and characterization of Caulobacter crecentus bacteriophage phi Cd1
Fravel et al. Effect of temperature, soil type, and matric potential on proliferation and survival of Fusarium oxysporum f. sp. erythroxyli from Erythroxylum coca
Rigby et al. Construction of intergeneric hybrids using bacteriophage P1CM: transfer of the Klebsiella aerogenes ribitol dehydrogenase gene to Escherichia coli
Dhillon et al. Temperate Coliphage HK022 Clear Plaque Mutants and Preliminary Vegetative Map
EP0396715A1 (en) Phage resistant ice nucleating pseudomonas syringae
Hashiba et al. Intraspecific protoplast fusion between auxotrophic mutants of Rhizoctonia solani.
Kelln et al. Isolation and properties of a bacteriophage lytic for a wide range of pseudomonads
Higgins et al. Slide culture observations of two freshwater Actinomycetes
Johnson Characteristics of a marine Vibrio-bacteriophage system
Ogata et al. A temperate phage of Streptomyces azureus
Renoux et al. Spontaneous lysis and phage-carrier state in Brucella cultures
Taylor et al. Concurrent changes in transducing efficiency and content of transforming deoxyribonucleic acid in Bacillus subtilis bacteriophage SP-10
OGATA et al. An investigation of the influence of bacteriophages on the bacterial flora and purification powers of activated sludge

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT CH DE FR GB IT LI SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENENCOR INTERNATIONAL, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930602